What is the catalog number for Citrate synthetase CS Rabbit Monoclonal Antibody?

The catalog number for Citrate synthetase CS Rabbit Monoclonal Antibody is orb548349.

What sizes are available for Citrate synthetase CS Rabbit Monoclonal Antibody?

Citrate synthetase CS Rabbit Monoclonal Antibody is available in the following size(s): 100 µL.

Is Citrate synthetase CS Rabbit Monoclonal Antibody in stock?

Citrate synthetase CS Rabbit Monoclonal Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

Citrate synthetase CS Rabbit Monoclonal Antibody

Anti-Citrate synthetase Rabbit Monoclonal Antibody. Tested in WB, IHC, ICC/IF, Flow Cytometry applications. This antibody reacts with Human, Mouse, Rat.

Product Specifications

Product Name Alternative

Hyaluronan mediated motility receptor; Intracellular hyaluronic acid-binding protein; Receptor for hyaluronan-mediated motility; CD168; HMMR; IHABP, RHAMM

UniProt

O75390

Reactivity

Human, Mouse, Rat

Immunogen

A synthesized peptide derived from human Citrate synthetase Carbohydrate metabolism; tricarboxylic acid cycle; isocitrate from oxaloacetate: step 1/2.

Target

Citrate synthase, mitochondrial

Clonality

Monoclonal

Clone

BCECQX5

Conjugation

Unconjugated

Field of Research

Cancer Biology, Cardiovascular Research, Metabolism Research, Neuroscience

Purification

Affinity-chromatography

Concentration

0.5mg/ml

Dilution

WB 1:500-2000 IHC 1:50-200 ICC/IF 1:50-200 FC 1:50

Form

Liquid

Molecular Weight

50 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

FC, ICC, IF, IHC, WB

Host or Source

Rabbit

Preservative

Rabbit IgG in stabilizing components, phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.